About Mehta Pharmaceutical
Mehta Pharmaceutical is a Healthcare company based in Mumbai (India) founded in 1998. It produces high-quality APIs and drug intermediates for pharmaceutical applications. It operates on a B2B model. Its Indian entity Mehta Antibiotics Private Limited reported revenue of ₹3.8 Lakh. Its focus areas include Pharmaceuticals, API Manufacturing and Drug Intermediates. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Mehta Pharmaceutical, established in 1998, excels in providing healthcare solutions, producing pharmaceutical products, api manufacturing, and drug intermediates. Produces high-quality APIs and drug intermediates for pharmaceutical applications. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Mumbai, India
- SectorsHealthcare
- Website mehtapharma.com
- Legal Name Mehta Antibiotics Private Limited
- Date of Incorporation 01 Mar, 2011
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹3.8 Lakh
FY 2025 · -12% YoY
- Net Profit₹2.8 Lakh
FY 2025 · 72% margin
- EBITDA₹2.4 Lakh
FY 2025 · 63% margin
Associated legal entities of Mehta Pharmaceutical
Mehta Pharmaceutical operates through Mehta Antibiotics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mehta Antibiotics Private Limited CIN U74900MH2011PTC214255 | Active | 01 Mar 2011 | Mumbai, Maharashtra | ₹0.0 Cr | 2 | View details |
Board of directors of Mehta Antibiotics Private Limited (Mehta Pharmaceutical)
Mehta Antibiotics Private Limited is the primary company behind Mehta Pharmaceutical. The board of Mehta Antibiotics Private Limited currently have 2 directors; the longest-serving is Atul Sureshchandra Mehta, appointed in 2011. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Atul Sureshchandra Mehta DIN 01558289 | Director | 01 Mar 2011 | 15 yrs 7 mo | Mehta Antibiotics Private Limited |
| Chetan Sureshchandra Mehta DIN 01558352 | Director | 01 Mar 2011 | 15 yrs 7 mo | Mehta Antibiotics Private Limited |
Financials of Mehta Pharmaceutical
Figures of Mehta Antibiotics Private Limited, the primary company behind Mehta Pharmaceutical, for FY 2025. Revenue was ₹3.8 Lakh (-12% year on year). Net profit was ₹2.8 Lakh (72% margin). EBITDA was ₹2.4 Lakh (63% margin). Revenue has grown at a compounded annual rate of -47% over three years and +54% over five years.
- ₹3.8 LakhRevenue · FY 2025 · -12% YoY
- ₹2.8 LakhNet profit · 72% margin
- ₹2.4 LakhEBITDA · 63% margin
- ₹13 LakhPaid-up capital
- -47%Revenue CAGR, 3 years
- +54%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Mehta Antibiotics Private Limited are on its company page.
Detailed financial statements for Mehta Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Mehta Pharmaceutical
Mehta Pharmaceutical has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Mehta Pharmaceutical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mehta Pharmaceutical
Mehta Pharmaceutical was founded in 1998.
Mehta Pharmaceutical is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Mehta Pharmaceutical, Mehta Antibiotics Private Limited, reported revenue of ₹3.8 Lakh for FY 2025, down 12% year on year.
Mehta Pharmaceutical, established in 1998, excels in providing healthcare solutions, producing pharmaceutical products, api manufacturing, and drug intermediates. Produces high-quality APIs and drug intermediates for pharmaceutical applications. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Mehta Pharmaceutical's top competitors include Laurus Labs, Symbiotec and SeQuent.
Mehta Pharmaceutical operates through Mehta Antibiotics Private Limited.
The legal entities of Mehta Pharmaceutical currently have 2 directors, including Atul Sureshchandra Mehta, Chetan Sureshchandra Mehta.